via John Innes Centre
Compounds tested for their potential as antibiotics have demonstrated promising activity against one of the deadliest infectious diseases – tuberculosis (TB).
Researchers from the John Innes Centre evaluated two compounds with antibacterial properties, which had been produced by the company Redx Pharma as antibiotic candidates, particularly against TB.
TB, which is caused by the bacterium Mycobacterium tuberculosis, is often thought of as a disease of the past. But in recent years it has been increasing due, in part, to rising resistance to treatments and decreasing efficacy of vaccines.
One strategy in the search for new treatments is to find compounds that exploit well-known existing targets for drugs such as the bacterial enzyme DNA gyrase. This member of the DNA topoisomerase family of enzymes is required for bacterial DNA functionality, so compounds that inhibit its activity are much sought after as antibiotic candidates.
Using X-ray crystallography, the team elucidated the molecular details of the action of the compounds against their target.
Surprisingly, a very common mutation in DNA gyrase that causes bacteria to be resistant to a related group of antibiotics, the aminocoumarins, did not lead to resistance to the compounds under scrutiny here.
“We hope that companies and academic groups working to develop new antibiotics will find this study useful. It opens the way for further synthesis and investigation of compounds that interact with this target,” says Professor Tony Maxwell one of the authors of the study which appears in the Journal of Antimicrobial Chemotherapy.
To date, efforts to develop new treatments for TB have been unsuccessful, with current treatments having been used for over 50 years.
World Health Organisation (WHO) figures reveal that each day over 4,000 people die from TB and 300,000 people fall ill from the disease. Nearly 500,000 people fell ill with drug-resistant TB in 2018.
Professor Maxwell says: “Antimicrobial resistance (AMR) is now well-recognised as one of the biggest problems facing us in the in the 21st Century. If we don’t find solutions to it soon, we could be looking at epidemics of bacterial disease going forward.”
“People know about the bubonic plague and other such terrible pestilence through studying history but it’s not overstating the case that bacterial diseases of this sort could reemerge if we do not have effective antibiotics. We must find a way of bringing together expertise from the academic and business sector towards decisive action.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Tuberculosis Control in New York City — A Changing Landscapeon September 4, 2020 at 6:31 pm
Varma, M.D. Since the introduction of chemotherapy for treating tuberculosis, political commitment and stable, sufficient funding have been the primary predictors of success for tuberculosis-control ...
- Can tuberculosis vaccine BCG prevent coronavirus infection? 5 trials are onon September 4, 2020 at 9:14 am
If BCG is indeed proven to be effective against COVID, India will gain on multiple counts. First of all, it can initiate the administration of a dose of BCG on adults without any safety concerns While ...
- Captive elephants can spread tuberculosis to humans—'an issue that’s been ignored'on September 4, 2020 at 6:41 am
As the coronavirus has heightened public awareness about disease transmission between animals and humans, some experts are warning about the risks of tuberculosis in captive U.S. elephants.
- Tamil Nadu Tuberculosis Patients In Tamil Nadu Get Medications Delivered To Themon September 3, 2020 at 2:25 am
Health Minister C. Vijayabaskar, in a press release, said medicines were delivered at the doorsteps of 52,489 patients ...
- When Tuberculosis Struck the World, Schools Went Outsideon September 1, 2020 at 8:35 am
Adolphus Knopf, a German-born expert on tuberculosis and the founder of the National Tuberculosis Association, which became the American Lung Association. Like many leading minds of his generation, ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Scientists develop new compound which kills both types of antibiotic resistant superbugson September 4, 2020 at 8:51 pm
Researchers at the University of Sheffield have developed a new compound that is able to kill both gram-positive and gram-negative antibiotic-resistant bacteria.
- Antiobiotics in our waterways puts millions in danger by increasing resistance to the drugs,on September 3, 2020 at 6:39 pm
High levels of antibiotics in rivers are putting millions of lives at risk by increasing bacterial resistance to the drugs, research suggests. NHS advice says resistance can create 'superbugs'.
- Medical waste in rivers raises threat of antibiotic resistanceon September 3, 2020 at 9:00 am
High levels of antibiotics in rivers and other waste water are putting people at increased risk of death from common infections as bacterial resistance to the drugs grows, research has suggested.About ...
- Evolution of antibiotic resistance at low antibiotic concentrations including selection below the minimal selective concentrationon September 3, 2020 at 8:19 am
Stanton et al. determine the minimal selective concentrations for macrolide and fluoroquinolone antibiotics and describe a selective window defined by the minimal increased persistence concentration.
- Safe thresholds for antibiotics in sewage needed to help combat antibiotic resistanceon September 3, 2020 at 8:12 am
New research reveals current understanding of safe antibiotic levels in rivers may not prevent evolution of antibiotic resistance and fully protect human health. The study suggests the need to ...